platinum has been researched along with Peripheral Nerve Diseases in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 1 (3.85) | 18.2507 |
| 2000's | 7 (26.92) | 29.6817 |
| 2010's | 7 (26.92) | 24.3611 |
| 2020's | 10 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, G; Alfaro, E; Cheung, S; Conley, YP; Cooper, B; Henderson-Sabes, J; Kober, KM; Levine, JD; Miaskowski, C; Paul, SM; Quinn, M; Snowberg, K; Topp, K | 1 |
| Blyta, A; Hundozi, Z; Hyseni, E; Jashari, F; Kurtishi, I; Myftiu, B; Qorraj Bytyqi, H; Sermaxhaj, F; Shala, N | 1 |
| Brouwer, J; de Jong, C; Deneer, VHM; Egberts, TCG; Herder, GJM; Ten Heuvel, A; van der Meer, FS; van Haarlem, SWA; van Lindert, ASR | 1 |
| Avakyan, GG; Chubykina, SV; Tatarinova, MY | 1 |
| Cao, Y; Chang, Q; Chen, EX; Hedley, D; Ornatsky, O; Zhang, W | 1 |
| Bandla, A; Chang, JK; Chayaburakul, K; Chew, WS; Herr, DR; Lam, BWS; Lopez, V; Ong, WY; Seow, WL; Sundar, R; Torta, F; Wang, W; Wenk, MR; Wong, P; Xiang, P | 1 |
| Geohagen, BC; Loeb, DM; LoPachin, RM; Nordstroem, LU; Weiser, DA | 1 |
| Goldstein, D; Kiernan, MC; Li, T; Mizrahi, D; Park, SB; Timmins, HC | 1 |
| Ding, R; Gu, J; Gu, Z; Huang, X; Huo, J; Li, L; Qin, F; Wei, G; Yu, J | 1 |
| Chang, CC; Chen, HF; Chen, SC; Hung, HW; Liu, CY | 1 |
| Kim, HS; Lee, M; Lee, N; Lee, S; Paik, H; Park, SJ; Yim, GW | 1 |
| Gao, L; Teng, H; Zhao, C; Zheng, Y | 1 |
| Abrams, G; Chesney, MA; Conley, YP; Cooper, BA; Kober, KM; Levine, JD; Mazor, M; Miaskowski, C; Paul, SM; Schumacher, MA; Topp, K; Wong, ML | 1 |
| Kocot-Kępska, M; Leppert, W; Mika, J; Wordliczek, J; Wrzosek, A; Zajączkowska, R | 1 |
| Aakre, JA; Johnson, C; Loprinzi, CL; Pankratz, VS; Staff, NP; Velazquez, AI; Windebank, AJ; Yang, P | 1 |
| Beck, SL; Brown, S; Kolb, NA; Mooney, K; Singleton, JR; Smith, AG; Stoddard, GJ | 1 |
| Ishibashi, K; Ishida, H; Miyazaki, T; Okada, N; Sano, M | 1 |
| Dmochowski, J; Greer, TB; Kiser, DW; Naumann, RW; Wilmoth, MC | 1 |
| Knight, A; McDonald, ES; Randon, KR; Windebank, AJ | 1 |
| Boku, N; Gotoh, M; Matsumura, Y; Muro, K; Mutoh, M; Nagashima, F; Ohtsu, A; Sano, Y; Shirao, K; Tanigawara, Y; Yamada, Y | 1 |
| Dzagnidze, A; Katsarava, Z; Kaube, H; Liedert, B; Limmroth, V; Makhalova, J; Thomale, J; Yoon, MS | 1 |
| Cavaletti, G; Minoia, C; Schieppati, M; Tredici, G | 1 |
| Ceballos, D; Navarro, X; Rodríguez, FJ; Schüttler, M; Stieglitz, T; Valderrama, E; Valero, A | 1 |
| Bayssas, M; Cavaletti, G; Dondè, E; Etienne, GG; Marmiroli, P; Minoia, C; Petruccioli, MG; Ronchi, A; Tredici, G; Tredici, P | 1 |
| Fischer, SJ; Gross, L; McDonald, ES; Windebank, AJ | 1 |
| DeGregorio, MW; Deisseroth, AB; Gandara, DR; George, CB; Kohler, M; Lawrence, HJ; Wilbur, BJ; Wold, H | 1 |
4 review(s) available for platinum and Peripheral Nerve Diseases
| Article | Year |
|---|---|
[Mechanisms of platinum-induced peripheral neuropathy in cancer patients].
Topics: Antineoplastic Agents; Humans; Neoplasms; Peripheral Nervous System Diseases; Platinum; Polyneuropathies; Quality of Life | 2023 |
Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review.
Topics: Antineoplastic Agents; Cancer Survivors; Humans; Life Style; Neurotoxicity Syndromes; Obesity; Peripheral Nervous System Diseases; Platinum; Quality of Life; Risk Factors; Taxoids | 2023 |
Platinum accumulation in oxaliplatin-induced peripheral neuropathy.
Topics: Antineoplastic Agents; Ganglia, Spinal; Heavy Metal Poisoning, Nervous System; Humans; Neurotoxicity Syndromes; Oxaliplatin; Peripheral Nervous System Diseases; Platinum | 2021 |
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; DNA Damage; Humans; Neoplasms; Oxidative Stress; Peripheral Nervous System Diseases; Platinum; Protein Kinase Inhibitors; Reactive Oxygen Species; Signal Transduction | 2019 |
2 trial(s) available for platinum and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind
Topics: Administration, Intravenous; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase III as Topic; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Pharmaceutical Preparations; Platinum; Quality of Life; Randomized Controlled Trials as Topic; Selenium | 2021 |
Phase I study of single-dose oxaliplatin in Japanese patients with malignant tumors.
Topics: Adult; Anorexia; Antineoplastic Agents; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Platinum | 2006 |
20 other study(ies) available for platinum and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Similarities in the Neuropathy Phenotype of Cancer Survivors Who Received Different Classes of Chemotherapy Drugs.
Topics: Antineoplastic Agents; Cancer Survivors; Humans; Neoplasms; Pain; Peripheral Nervous System Diseases; Phenotype; Platinum; Quality of Life; Taxoids | 2022 |
Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving 4-6 Cycles of Platinum-Based and Taxane-Based Chemotherapy: A Prospective, Single-Center Study from Kosovo.
Topics: Antineoplastic Agents; Bridged-Ring Compounds; Humans; Kosovo; Peripheral Nervous System Diseases; Platinum; Platinum Compounds; Prospective Studies; Taxoids | 2022 |
Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy.
Topics: Carcinoma, Non-Small-Cell Lung; Follow-Up Studies; Humans; Lung Neoplasms; Peripheral Nervous System Diseases; Platinum; Prospective Studies | 2023 |
Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Colorectal Neoplasms; Female; Fluorouracil; Heavy Metal Poisoning, Nervous System; Humans; Leucovorin; Limit of Detection; Male; Mass Spectrometry; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Platinum; Skin | 2019 |
Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy.
Topics: Animals; Antineoplastic Agents; Axons; Biomarkers; Cisplatin; Female; Humans; Lysophospholipids; Myelin Sheath; Neuroglia; PC12 Cells; Peripheral Nervous System Diseases; Platinum; Rats; Rats, Sprague-Dawley; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors | 2020 |
Enolate-forming compounds provide protection from platinum neurotoxicity.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Humans; Male; Mice; Neurotoxicity Syndromes; Organoplatinum Compounds; Peripheral Nervous System Diseases; Platinum; Rats | 2020 |
Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy.
Topics: Antineoplastic Agents; Cross-Sectional Studies; Female; Humans; Lung Neoplasms; Male; Peripheral Nervous System Diseases; Platinum; Quality of Life; Taiwan | 2021 |
Investigation on effect of basalin coated silver nanoparticles as antioxidant for alleviating peripheral neuropathy in mice treated with oxaliplatin.
Topics: Aluminum; Aniline Compounds; Animals; Antioxidants; Apoptosis; Brain; Metal Nanoparticles; Mice; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Platinum; Silver; Spectroscopy, Fourier Transform Infrared; TRPA1 Cation Channel | 2017 |
Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.
Topics: Aged; Antineoplastic Agents; Bridged-Ring Compounds; Cancer Survivors; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasms; Pain; Patient Reported Outcome Measures; Peripheral Nervous System Diseases; Platinum; Self Report; Surveys and Questionnaires; Taxoids | 2019 |
Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Cohort Studies; DNA Modification Methylases; DNA Repair Enzymes; Female; Glutathione Peroxidase; Humans; Lung Neoplasms; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Peripheral Nervous System Diseases; Peroxidases; Platinum; Polymorphism, Single Nucleotide; Risk Factors; Taxoids; Tumor Suppressor Proteins | 2015 |
The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
Topics: Accidental Falls; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compounds; Chi-Square Distribution; Female; Humans; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Ovarian Neoplasms; Peripheral Nervous System Diseases; Platinum; Prospective Studies; Severity of Illness Index; Taxoids | 2016 |
[Changes in peripheral neuropathy and platinum concentrations in patients undergoing surgery following modified FOLFOX6 therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Erythrocyte Count; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Peripheral Nervous System Diseases; Platinum | 2008 |
Peripheral neuropathy in patients with gynecologic cancer receiving chemotherapy: patient reports and provider assessments.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Genital Neoplasms, Female; Humans; Middle Aged; Neurotoxins; Nursing Assessment; Oncology Nursing; Patient Education as Topic; Peripheral Nervous System Diseases; Platinum; Retrospective Studies; Taxoids; Young Adult | 2010 |
Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cells, Cultured; Cisplatin; DNA; DNA Adducts; Female; Ganglia, Spinal; Nerve Degeneration; Nerve Growth Factor; Neurons, Afferent; Neurotoxins; PC12 Cells; Peripheral Nervous System Diseases; Platinum; Rats; Rats, Sprague-Dawley; Time Factors | 2005 |
Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Analysis of Variance; Animals; Cisplatin; Deoxyguanine Nucleotides; Disease Models, Animal; DNA Adducts; DNA Repair; Electric Stimulation; Ganglia, Spinal; Male; Mice; Mice, Knockout; Neural Conduction; Neuroglia; Neurons; Organoplatinum Compounds; Peripheral Nervous System Diseases; Platinum; Time Factors; Xeroderma Pigmentosum Group A Protein | 2007 |
Protective effects of glutathione on cisplatin neurotoxicity in rats.
Topics: Animals; Cisplatin; Disease Models, Animal; Drug Interactions; Female; Ganglia, Spinal; Glutathione; Neurons, Afferent; Peripheral Nervous System Diseases; Platinum; Rats; Rats, Wistar | 1994 |
Polyimide cuff electrodes for peripheral nerve stimulation.
Topics: Animals; Electric Stimulation; Electrophysiology; Female; Microelectrodes; Motor Neurons; Movement; Muscle Fatigue; Nerve Fibers, Myelinated; Neural Conduction; Neurons, Afferent; Neurosciences; Peripheral Nervous System Diseases; Platinum; Prosthesis Implantation; Rats; Rats, Sprague-Dawley; Resins, Synthetic; Sciatic Nerve | 2000 |
Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Evoked Potentials, Auditory; Female; Injections, Intraperitoneal; Microscopy, Electron; Neural Conduction; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Platinum; Rats; Rats, Wistar; Tail | 2001 |
Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Cycle; Cisplatin; Cyclin D1; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Ganglia, Spinal; Immunohistochemistry; In Situ Hybridization; In Situ Nick-End Labeling; Nerve Degeneration; Neurons, Afferent; Neurotoxins; Pain Measurement; Peripheral Nervous System Diseases; Platinum; Rats; Rats, Sprague-Dawley; Renal Insufficiency; RNA, Messenger; Up-Regulation | 2001 |
High-dose cisplatin in hypertonic saline: reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Group Pilot Study in non-small-cell lung cancer.
Topics: Adult; Aged; California; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Kinetics; Lung Neoplasms; Male; Middle Aged; Peripheral Nervous System Diseases; Pilot Projects; Platinum; Saline Solution, Hypertonic | 1986 |